Re: The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multicenter, Prospective Registry Study

Affiliations

¹ Department of Breast Oncology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan.
² Department of Breast Oncology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan. horimoto@juntendo.ac.jp.

Comment

Yumiko Ishizuka et al. Ann Surg Oncol. 2021 Dec.

. 2021 Dec;28(Suppl 3):784.

doi: 10.1245/s10434-021-10528-7. Epub 2021 Sep 12.

¹ Department of Breast Oncology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan.
² Department of Breast Oncology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan. horimoto@juntendo.ac.jp.

No abstract available

Comment in

Reply: The Effect of Primary Surgery in Patients with Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-center, Registry Study.
Soran A, Sezgin E, Ozbas S, Dogan L; Breast Health Working Group International. Soran A, et al. Ann Surg Oncol. 2021 Dec;28(Suppl 3):782-783. doi: 10.1245/s10434-021-10396-1. Epub 2021 Jul 7. Ann Surg Oncol. 2021. PMID: 34232420 No abstract available.

The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-Center, Prospective Registry Study.
Soran A, Dogan L, Isik A, Ozbas S, Trabulus DC, Demirci U, Karanlik H, Soyder A, Dag A, Bilici A, Dogan M, Koksal H, Sendur MAN, Gulcelik MA, Maralcan G, Cabioglu N, Yeniay L, Utkan Z, Simsek T, Karadurmus N, Daglar G, Yildiz B, Uras C, Tukenmez M, Yildirim A, Kutun S, Ozaslan C, Karaman N, Akcay MN, Toktas O, Sezgin E. Soran A, et al. Ann Surg Oncol. 2021 Sep;28(9):5048-5057. doi: 10.1245/s10434-021-09621-8. Epub 2021 Feb 2. Ann Surg Oncol. 2021. PMID: 33532878

1. Soran A, Dogan L, Isik A, Ozbas S, Trabulus DC, Demirci U, et al. The effect of primary surgery in patients with de novo stage IV breast cancer with bone metastasis only (protocol BOMET MF 14–01): a multi-center, prospective registry study. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-09621-8 . - DOI - PubMed
1. Badwe R, Hawaldar R, Nair N, Kaushik R, Parmar V, Siddique S, et al. Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial. Lancet Oncol. 2015;16:1380–8. - DOI
1. Khan SA, Zhao F, Solin LJ, Goldstein LJ, Cella D, Basik M, et al. A randomized phase III trial of systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer: a trial of the ECOG-ACRIN Research Group (E2108). J Clin Oncol. 2020;38:LBA2. - DOI